Facial Injectable Market Trends, Emerging Audience, Segments, Profits and Competitor Landscape

Facial injections are also popular as facial fillers. These are used to rejuvenate facial skin by reducing wrinkles, enhancing lips, raising scar depression, etc. Normally, over-exposure to the sun and an increase in age lead to wrinkles and sagging.

Market Overview

Facial injections are also popular as facial fillers. These are used to rejuvenate facial skin by reducing wrinkles, enhancing lips, raising scar depression, etc. Normally, over-exposure to the sun and an increase in age lead to wrinkles and sagging. Facial injections can correct all these health issues. There are various types of injections available for temporary and permanent purposes. A qualified medical professional can guide the suitable filler and the procedure to be followed. Many facial fillers are available in the market, out of which Juvéderm facial filler (made of the hyaluronic acid gel used to correct facial wrinkles and folds), and Restylane facial filler (which is a soft tissue dermal filler) are popular. A facial filler treatment session depends on the area to be treated. Generally, one session takes 10 to 20 minutes. Some of the side effects of this treatment are allergic reaction, bruising at the injection site, temporary redness or swelling, etc. An increase in demand to look good with minimally invasive procedures majorly drives the facial injectable market. Like all other markets, even the facial injectable market was affected during the pandemic situation COVID’19. The strict imposition of lockdown by respective governments restricted people to visit the hospitals as the main focus was on treating COVID’19 patients. However, since the situation is coming under control, there is a chance of growth in the market.

Market Segmentation

The facial injectable market is segmented based on the type, end-user, application, and geography. According to the type category, it is divided into the dermal filler and anti-ageing injections. Dermal fillers are further bifurcated into hyaluronic acid fillers, collagen, and synthetic fillers. On the other hand, anti-aging is bifurcated into botulinum toxin A and poly L lactic acid. An end-user category is categorized into hospitals, beauty clinics, dermatology clinics, and research institutes. According to the applications category, it is classified into aesthetics and therapeutics. Geography-wise, the market is divided into North America, Europe, Asia-Pacific, and the rest of the world.

Regional Classification

According to the type category, botulinum toxin A related to the anti-ageing segment dominates the facial injectables market. The hyaluronic acid fillers under the dermal fillers segment have the largest share due to their ability to store moisture in the skin, resulting in healthier skin. The aesthetics segment of the application category contributes maximum share to the market. The beauty and dermatology clinics contribute maximum to the facial injectable market. The North American segment in the geography category dominates the market due to the affordability of treatment costs, increased awareness of treatments, etc.

Industry News

The global analysis of the facial injectable market reveals that the market will reach a revenue of 27.7 billion USD at a CAGR of 8.8% by the end of 2028. A new trend has started. People belonging to the age group of 10-70 years have become over conscious of their appearance. The desire to look good has increased the facial injectable market. An increase in research and development activities, awareness of the treatment, etc., also drive the market. However, the side effect of the treatment, cost of the treatment are some factors that hamper the market. 

Competitive Landscape

The Facial Injectable Market player are Eisai Co., Ltd, Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson and Johnson Services Inc., Mylan N. V., Novartis AG, Novo Nordisk, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd, and Inovio Pharmaceuticals Inc. focus on expanding their presence in emerging market and maintains strong distributor relationships.

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com